3A3184).
Introduction
Integrins are a superfamily of adhesion receptors which mediate cell-to-cell and cell-to-matrix interactions in various biological processes such as embryogenesis, wound healing, blood coagulation, immune response, and metastasis formation (1-4). At least 12 a-( 5 ) , and eight P-chains (6) have been described in human, which associate to form 21 different heterodimers.
Although some integrins, e.g., the VLA family and a&, are expressed in several types of cells of different embryological origin, others have a more restricted distribution. Among them, the integrin complex a& has been long considered to be limited to epithelial cells (7-9), although recently it has been described in endothelial cells of small vessels in mice (10) and in human Schwann and perineurial cells (llJ2). In squamous epithelia, a& is present exclusively in basal cells, where it co-localizes with hemidesmosomal components recognized by bullous pemphigoid antigen antibodies (13) . Finally, immunoelectron microscopy has shown colocalization between the complex a& and hemidesmosomes (14-16). Although it is uncertain whether this integrin complex associates exclusively with hemidesmosomes, the majority of authors exclude the presence of a& in adhesion structures containing actin (17J8).
Very little is known about the functional role played by this integrin complex. Antibodies against either a6 or P4 are able to inhibit the assembly of hemidesmosomes in an epithelial cell line (804G) forming hemidesmosomes in culture, suggesting that a& may act as a nucleating center for these adhesion structures (16) . On the other hand, antibodies to 8 4 impair adhesion of keratinocytes in vitro (19, 20) .
Recently, the extracellular ligand of a& has been identified as laminin (21), but the published data do not formally disprove that other matrix proteins are the major ligands of this complex;
candidates for this role are the epiligrin-kalinin-BM6OOlnicein complex (22) and conformational ligands formed by the association of different basement membrane components, including laminin.
In the present study we report that (a) the a 6 and p4 integrin subunits are expressed by a subset of smooth muscle cells present in the media of the microvasculature; (b) in these cells, both a 6 and 84 chains are closely co-localized with a-smooth muscle actin (a-SMA) filaments in restricted areas, thus suggesting a new association of a& complex with cytoskeletal structures; and (c) of the possible asp4 ligands described above, only laminin is present in a&-containing vessels.
Materials and Methods
Tissues. In this study we examined normal human specimens from different anatomic regions: skin, heart, kidney, liver, striated muscle, brain, and large vessels. All samples were obtained from surgical biopsies (skin, striated muscle, and kidney samples) or from very early autopsies (less than 2 hr). The tissues were embedded in OCT 4583 (Miles Scientific; Napervile, E) and quick-frozen in isopentane pre-cooled in liquid nitrogen. Threepm frozen serial sections were cut in a Leitz 1720 cryomicrotome, transferred onto microscope slides coated with 3-aminopropyl-triethoxysilane (Flub, Buchs, Switzerland) to improve the adhesiveness of the sections, fixed in a chloroform-acetone mixture (1:l) at 4°C for 10 min, briefly airdried, and immediately processed for indirect immunofluorescence.
Antibodies. The primary mouse monoclonal antibodies (MAb) used in this study, with the investigators who kindly provided them, are as follows: GOH3 to a6 from A. Sonnenberg. The Netherlands Cancer Institute, Amsterdam, The Netherlands; MAR6 to a6 from S. MEnard (26) from W. G. Carter, Fred Hutchinson Cancer Center, Seattle, WA. All the above MAb were IgGl and each was carefully tested to exclude any crossreaction with secondary antibodies to IgGza. Anti-aSM-1, an IgG2, directed specifically against a-smooth muscle actin (27) . was used for double immunofluorescence staining with all the monoclonal and polyclonal antibodies used in the present study. Rabbit polyclonal antisera 6842 and 6844 to a6 were generously provided by V. Quaranta, and rabbit antisera to laminin, collagen Type IV, and Factor VIII-related antigen (von Willebrand factor) were respectively from Sigma (St Louis, MO), Hey1 (Berlin, Germany), and BioMakor (Rehovot, Israel).
The rabbit antiserum SP90395 was raised against a synthetic peptide of 17 amino acids corresponding to the COOH terminal of the integrin chain 8 4 (28, 29 ). An affinity column was made by coupling 500 pg of the above peptide to a HiTrap NHS-activated column (Pharmacia; Uppsala, Sweden) according to the manufacturer's instructions. Monospecific antibodies (from the SP90395 serum) were eluted in low-pH buffer, dialyzed against PBS, and used for immunohistochemistry at a S-lO-pg/ml concentration.
All the other monoclonal and polyclonal antibodies were used at a final dilution of 1:50-1:100, except for anti-aSM-1, which was always used at an IgG concentration of 0.15 pglml.
Indirect immunofluorescence Tkchnique. Double immunofluorescence staining was performed with a mixture of anti-aSM-1 with each of the other monoclonal (IgG1) and polyclonal antibodies against a 6 or 84. The sections were overlaid with 50 p1 of the different antibodies and were incubated at room temperature (RT) in a moist chamber for 1 hr. After rinsing in PBS three times for 5 min, sections were incubated with the appropriate secondary antibodies for 30 min at RT. The secondary antibodies used were a fluorescein isothiocyanate (FITQconjugated goat anti-mouse IgG2, (Nor-dic Immunology; Tilburg, The Netherlands) diluted 1:40, a tetramethyl rhodamine isothiocyanate ("IC)-conjugated goat anti-mouse IgGl (Nordic) diluted 1:20, a dichlorotriazinyl amino fluorescein (DTAF)-conjugated goat anti-mouse IgG+ IgM (Jackson ImmunoResearch; West Grove, PA) diluted 180, and a "IC-conjugated goat anti-rabbit IgG (Jackson) diluted 1:30. To minimize the background staining, secondary antibodies were preabsorbed on a solid immunoabsorbent of human serum cross-linked with glutaraldehyde (30) . After several rinsings in PBS, the sections were mounted in buffered polyvinyl alcohol (31) . Negative controls were performed on adjacent sections on the same slide, replacing each primary antibody with non-immune IgG. Observations were carried out with a Zeiss Axiophot photomicroscope (Carl Zeiss; Oberkochen, Germany) equipped for epifluorescence; images were usually recorded on a Kodak T-Max 400 film (Kodak, Hemel, Hempstead, UK), exposed at 1000 ISO, using a plan apochromatic 40x 11.3 or 63 x 11.4 objective.
Confocal Laser Scanning Fluorescence Microscopy (CUM). Basically, the same specimens prepared for indirect immunofluorescence were also used for confocal microscopy; sometimesp-phenilendiamine was added to the mounting medium to reduce the rapid bleaching produced by the laser illumination (32) . For some samples double stained with polyclonal and monoclonal antibodies, a Texas Red-conjugated goat anti rabbit IgG was used instead of the rhodamine analogue to rule out the slight overlapping of the excitation and emission spectra of fluorescein and rhodamine. For all the obsenations we used a Zeiss confocal microscope (Carl Zeiss) equipped with two different lasers, an argon ion laser (emission at 488 nm and 514 nm) and an He-Ne laser (emission at 545 nm). The combination of filters to separate efficiently the excitation and emission spectra of the different fluorochromes was as follows: laser wavelength bandpass filter 488l 545 nm, primary dichroic beamsplitter 4881545 nm, secondary dichroic beamsplitter 545 nm, detector 1 longpass filter >600 nm (rhodamine or Texas Red channel) and detector 2 narrow-band filter 510-525 nm (fluorescein channel). The objectives used were an immersion oil plan-neofluoar 40x/1.3 and a plan-apochromatic 63 x 11.4 (Carl Zeiss); images of 512 x 512 pixels were stored on an erasable optical disk (Sony; Tokyo, Japan) and then photographed on a color slide film with a freeze-frame digital camera (Focus Graphics; Genhe, Switzerland).
Results
Step-frozen sections of human skin, heart, kidney, liver, striated muscle, and brain were analyzed by double-label indirect immunofluorescence using an anti-aSM-1 and different mono-and polyclonal antibodies to the aand p-subunits of the integrin complex a&. Distinct fluorescence for both p4 (Figures Ib, Id , and I f ) and a6 was observed in the small vessels present in these tissues, both arterioles and small veins; in many areas the distribution of a6 and 84 was coincident with that of a-SMA (Figures la, IC, and le). The same pattern of distribution was found with all the monoand polyclonal antibodies tested, i.e., GOH3, MAR6, R6842, and R6844 for a6 and AA3, S3-41, 3E1, and SP90395 for p4. Vessels of larger size, such as aorta ( Figures Ig-lh) , and uterine or coronary arteries did not show positivity for a 6 or 04. In all cases, antibodies to a 6 and p4 were checked in the epidermis of skin s a mples and gave the typical pattern reported for epidermal a& complex (data not shown).
The possible expression of a 6 and p4 was also studied in myometrium and in other types of muscle tissue, such as skeletal and myocardial muscle (data not shown). We found that in the myometrium there was faint staining of smooth muscle cells for a6 but not for p4; skeletal muscle and myocardial fibers expressed neither a6 nor B4. Of the matrix proteins considered as possible ligands of the integrin complex a&. we have investigated the epiligrin-kalinin-BMGOOlnicein complex and laminin. No staining for the complex was observed in small vessels (Figures 2c and 2d ), but a sharp, linear reactivity was found in the epidermal basement membrane of skin samples. Staining for laminin was present in the media of small vessels as well as in the subendothelial region (Figures 2a and 2b) .
The use of a confocal microscope was considered essential to determine whether the localization of a6 and j34 was within the smooth muscle layer of small vessels. The confocal microscope eliminates the out-of-focus problems present in conventional epifluorescence microscopy which makes it difficult to localize dualwavelength fluorescent signals precisely. As a result of this analysis, the anti-as polyclonal antibody R6844 gave a perfect colocalization with the anti& MAb 3E1 (Figure 3a ) and the same anti& MAb was found to be external to the endothelial layer, stained with von Willebrand factor polyclonal antibodies ( Figure  3b ). Furthermore, the labeling for the p4 chain, performed with several different monoclonal and polyclonal antibodies, was confirmed to be inside the media, where smooth muscle cells were stained with anti-aSM-1 MAb (Figures 3c and 3d) . In some vessels, the labeling for both a6 and 84 integrin chains was extensively su-perposed with the staining for a-SMA (Figure 3c ), whereas in other vessels the labeling for the two integrin chains was only partially coincident with the labeling for a-SMA ( Figure 3d ). Different controls were performed to exclude the presence of fluorescein signal (for a-SMA) in the rhodamine channel for a6 and (j4), or vice versa, owing to the partial superposition of the emission spectra of the two fluorochromes. After several trials we decided to use an F I X -or DTAF-conjugated secondary antibody to detect the strongest signal, i.e., a-SMA, to partially compensate the intense bleaching of fluorescein produced by laser illumination. After a careful selection of different combinations of beamsplitters and barrier filters, no signal in the rhodamine channel was detected when the staining was performed with only FITCconjugated secondary antibody and, conversely, no signal was detected in the fluorescein channel when the staining was performed with only TRITC-conjugated secondary antibody. Furthermore, the double labeling with fluorescein (anti-aSM-1) and Texas Red (polyclonal antibody SP90395) gave the same result as double stainings with fluorescein (anti-aSM-1) and rhodamine (all the monoclonal and polyclonal antibodies against a6 or j34 integrin chains) (not shown). 
DiscusSion
Previous studies on the distribution of the a6 and 84 integrin subunits have already shown a specific localization of these chains in the small-sized vasculature (10,33) but not in coincidence with smooth musde cells. In particular, Kennel et d. (10) reported that in mice, endothelia of intermediate vessels throughout the body are sites of 84 expression. The authors' conclusions were supported by low-magnification micrographs of different tissues stained with a radioactively labeled anti434 monodonal antibody (346-1lA). No specific markers for endothelium or smooth m d e cells were used in combination with this antibody . Natlli et d. (33) reported that the labeling for both and 84 was localized in the subendothelial space of human small vessels, mostly small veins and lymphatics. In both studies, the adopted microscopic resolution was too low to obtain a precise discrimination of signals located in the closely apposed medial and intimal compartments. Our work shows that in small human vessels, the integrin heterodimer a& is localized at the level of medial smooth muscle cells and suggests that the above mentioned studies should be reinterpreted on this basis. We feel sufficiently confident to assume that a684 is present in connection with smooth muscle cells of the microvasculature but that further work is needed to determine whether smooth muscle cells of lymphatic vessels also contain these integrins.
We have performed double-label immunofluorescence experiments using markers specific for both endothelial (von Willebrand factor) and smooth muscle cell (a-SMA) components in combination with several monoclonal and polyclonal antibodies against a6 or B4 specific for their extracellular and cytoplasmic domains. To evaluate the co-distribution of all these antibodies, we have analyzed our specimens by means of CUM. The reasons for this choice depend (a) on the higher resolution of CUM in comparison with conventional immunofluorescence owing to the virtual absence of out-of-focus problems, (b) on the possibility of using extremely selective filters to effectively separate different fluorochromes, i.e., TRITC-FITC or Texas Red-FITC, and (c) on the intrinsic difficulty (experienced after several trials) of performing ultrastructural labeling with different monoclonal and polyclonal antibodies in structurally well-preserved specimens such as those embedded in h i c r y 1 resin. The loss of intensity of both excitation and emission radiations owing to the use of narrow-band or bandpass filters is compensated by strongly emitting singleor double-wavelength laser sources and by electronic photomultipliers. The result is a final image with a higher resolution than that provided by ordinary epifluorescence and with a sharper separation of different fluorescent signals. The possible technical problem of an incomplete separation of FITC and TRITC excitation and emission spectra, also after a careful selection of filters, was excluded by using, in some experiments, Texas Red instead of TRITC, in combination with F I X , and by performing some labelings with only one fluorochrome, F I X or TRITC. In the latter case, no signal was recovered in the corresponding "blind' channel.
Our data derived by confocal microscopy strongly support the localization of the 06 and 8 4 integrin subunits in a-SMA-containing cells of small vessels, i.e. in the smooth muscle cells of the media of the microvasculature. Furthermore, we show a partial colocalization of p4 integrin chain with a-SMA-containing cytoplasmic areas.
Thus far, the p4 chain has been invariably found in association with the a6-subunit, forming the a& integrin complex; instead, the as-subunit can form two different heterodimers, one of them in association with the pl chain (34). Based on,these considerations, the presence of both a6 and p4 chains in the smooth muscle cells of small vessels can be interpreted as the specific expression of the asp4 complex, but no direct biochemical data are given to support this consideration owing to obvious technical problems. For this purpose it will be necessary either to develop a technique for the selective isolation of smooth muscle cells of small vessels or to use an in situ hybridization procedure with p4 cDNA probes with resolution sharp enough to show the specific presence of p4 mRNA in smooth muscle cells.
Although in epithelial cells the a& complex is associated with hemidesmosomes, these structures have not been described in smooth muscle cells. The distinct co-localization, in some restricted areas, of the a6 and B4 integrin chains with a-SMA and the presence of focal contact equivalents in dense plaques of smooth muscle cells (35) suggest an association of a& subunits with known adhesion plaque components such as actin, vinculin, and a-actinin. The possible association of the a6 and p4 integrin chains with intermediate filament proteins such as vimentin and desmin, in analogy with their association with keratin in epithelial cells, should be considered. The specific expression of splicing variants for either a6 (36, 37) or p4 chains (29) is consistent with the possibility that these integrins exhibit an affinity for actin or actin-associated proteins in smooth muscle cells, in addition to the affinity for hemidesmosome components. All the antibodies against p4 or a6 used in our experiments do not discriminate among splicing variants of these integrin subunits.
Of the possible ligands of the a& complex, we have investigated laminin and kalinin-epiligrin-BM6OO/nicein. BMbOO/nicein i s a 600 KD complex formed by peptides linked by disulfide bonds (38) . In normal skin it is found in the basement membrane zone immediately undemeath the basal surface of basal epidermal cells, similar to laminin or collagen Type IV (39) . This position pairs that of a&, which is conversely a protein of the basal surface of the same cells (19) . Epiligrin (26) and kalinin (25) have been described to display the same localization of BMbOO/nicein in intact skin and to be formed by peptides of slightly different molecular masses. According to recent studies, these proteins are antigenically related and biologically identical (22) . Laminin was recently identified as the ligand of the a& complex on the basis of adhesion tests and affinity chromatography on laminin-Sepharose columns (21). The very low inhibition of adhesion by specific antibody against 8 4 (30% inhibition) cannot exclude the presence of other molecules, perhaps derived from laminin, that can bind the a& complex more efficiently. The recently discovered partial sequence of the BMGOOlnicein complex has revealed a high homology with the A-chain of laminin (Ortonne JP, personal communication). In small vessels, we have found that only laminin was in relation to smooth musde cells, supporting the possibility that this matrix component is the ligand of the a& complex in cells of mesenchymal origin.
We have no explanation for the restricted expression of a6 and 0 4 integrin subunits in a specific subpopulation of smooth muscle cells. This finding is in agreement with previous work suggesting a phenotypic heterogeneity of vascular smooth muscle cells detected by sensitivity to different growth factors, vasoactive substances, and drugs (reviewed in 40) and by the expression of distinctive cytoskeletal proteins (41) (42) (43) . At present, no data are available to explain the presence and function of these different subpopulations of vascular smooth muscle cells. The integrin complex asp4 can therefore be considered as a new marker of heterogeneity of smooth muscle cells of small vessels.
In conclusion, our findings demonstrate the presence of a6 and p4 integrin subunits in the media of the microvasculature, mostly in association with a-SMA; no staining for both a6 and $4 was present in the endothelial cells of the same vessels. Furthermore, we propose the a6 and $4 integrin subunits as new markers of a restricted subpopulation of vascular smooth muscle cells.
